Crew Capital Management, Ltd. Pfizer Inc Transaction History

Crew Capital Management, Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	SELL	$32.09 - $37.51 $6,770 - $7,914	-211 Reduced 3.31%	6,164 $204,000
Q2 2023 Jul 20, 2023	SELL	$36.12 - $41.79 $14,447 - $16,716	-400 Reduced 5.9%	6,375 $233,000
Q4 2022 Jan 18, 2023	SELL	$41.75 - $54.5 $22,169 - $28,939	-531 Reduced 7.27%	6,775 $0
Q4 2021 Feb 07, 2022	SELL	$41.32 - $61.25 $21,693 - $32,156	-525 Reduced 6.7%	7,306 $431,000
Q3 2021 Oct 18, 2021	BUY	$39.25 - $50.42 $8,831 - $11,344	225 Added 2.96%	7,831 $337,000
Q2 2021 Aug 09, 2021	SELL	$35.91 - $40.68 $4,488 - $5,085	-125 Reduced 1.62%	7,606 $298,000
Q1 2021 Apr 30, 2021	BUY	$33.49 - $37.77 $258,911 - $291,999	7,731 New	7,731 $280,000

3,267

3.73B

74.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Crew Capital Management, Ltd., based on Form 13F filings with the SEC.

Stay updated on Crew Capital Management, Ltd. with notifications on news.